Chelsea defender Fofana was left baffled by the medical location

tennis player

Wesley Fofana’s medical was one of the reasons for the widening of discontent between Chelsea owners and ex-manager Thomas Tuchel.

Chelsea star defender Wesley Fofana was left baffled after being informed that his medical will be held in the US. Fofana joined Chelsea in the summer window from Leicester for a fee of £69.5m. However, before joining his new teammates at Stamford Bridge, he had his medical in the United States. Owner Todd Boehly was concerned with Fofana’s injury record. Consequently, he wanted Fofana to be checked by his US-based medical team to ensure that he was completely fit.

Fofana told L’Equipe ( getfrenchfootballnews) that the doctor of the LA Lakers carried out his medicals. Furthermore, he added that the medical lasted for 10 hours and was very thorough. Fofana said:

“…It was the [Los Angeles] Lakers doctor who supervised all the tests, he looked at everything….It lasted over 10 hours! It’s normal given the amount of money spent on me. Todd [Boehly] and Bedhad [Eghbali] (the Chelsea owners) were great…”

However, according to a new report by the Metro, ex-Chelsea manager Thomas Tuchel saw this as a ‘power play’. Additionally, the ex-Chelsea manager was of the view that this move was unnecessary. Moreover, the player was fighting jet lag after making his return to the UK. This hampered his performance in training. Furthermore, this was one of the several reasons that led to the deterioration of Tuchel’s and Todd Boehly’s relationship which led to the firing of Tuchel.

Fofana made his Chelsea debut against West Ham, three days after joining them. However, he was on the substitution bench for the new manager Graham Potter’s first match for Chelsea. The game ended in a 1-1 draw thanks to goals by Raheem Sterling for Chelsea and Okafor for Salzburg. Consequently, the Blues are now at the bottom of their Champions League group.

As featured on

For more sports updates, make sure to follow us on Twitter, Facebook, Instagram & LinkedIn.

To Top